drugset / Trial / NCT04187196

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

NCT04187196

Phase 4 Completed 73 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized, open-blinded, prospective study to evaluate the timeliness and safety of direct current cardioversion (DCCV) when using methohexital when compared to the more often used propofol.

Timeline

Start
2020-04-29
Primary completion
2022-09-28
Completion
2022-09-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Methohexital Small molecule 0.5 mg/kg
Subject Propofol Small molecule 0.8 mg/kg